Iodine-125 seed implantation in the treatment of malignant tumors

Malignant tumors are major causes of morbidity and mortality in China. Despite advances in surgical, radiological, chemotherapeutic, molecular targeting, and immunotherapeutic treatments, patients with malignant tumors still have poor prognoses. Low-dose-rate brachytherapy, specifically (125)I seed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Pan, Huang, Jianwen, Zhang, Yanling, Guo, Huanqing, Chen, Guanyu, Zhang, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Journal of Interventional Radiology Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577067/
https://www.ncbi.nlm.nih.gov/pubmed/37846333
http://dx.doi.org/10.1016/j.jimed.2023.07.006
Descripción
Sumario:Malignant tumors are major causes of morbidity and mortality in China. Despite advances in surgical, radiological, chemotherapeutic, molecular targeting, and immunotherapeutic treatments, patients with malignant tumors still have poor prognoses. Low-dose-rate brachytherapy, specifically (125)I seed implantation, is beneficial because of its high local delivery dose and minimal damage to surrounding tissues. Consequently, it has gained increasing acceptance as a treatment modality for various malignant tumors. In this study, we explored the fundamental principles, clinical applications, and new technologies associated with (125)I radioactive seed implantation.

Ejemplares similares